Infusion of autologous mononuclear bone marrow cells
CMMo/MD/2013
Phase 2 small_molecule terminated
Quick answer
Infusion of autologous mononuclear bone marrow cells for Idiopathic Dilated Cardiomyopathy is a Phase 2 program (small_molecule) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Idiopathic Dilated Cardiomyopathy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated